Govers-Riemslag J W, Johnsen L, Petrovan R J, Rosing J, Tans G
Cardiovascular Research Institute Maastricht, Maastricht University, The Netherlands.
Thromb Res. 1998 Dec 1;92(5):239-47. doi: 10.1016/s0049-3848(98)00144-3.
Activation of prothrombin by multisquamase, the prothrombin activator from the venom of Echis multisquamatus (Central Asian sand viper), is inhibited by membranes containing negatively charged anionic phospholipids. This inhibition appears to be due to the fact that the venom activator cannot activate membrane-bound prothrombin. Initial steady state rates of prothrombin activation by multisquamase in the presence of phospholipids appeared to depend on the fraction unbound prothrombin only and this phenomenon was used to quantitate binding of prothrombin to membranes of varying phospholipid composition. In this method, the initial rate of prothrombin activation by multisquamase is measured in the absence (total prothrombin) and in the presence of a procoagulant surface (rate depending only on free prothrombin) and from the difference in activation rates the amount of membrane-bound prothrombin is calculated. The validity of the method was established by determination of the binding parameters for prothrombin binding to 100 microM phospholipid vesicles composed of 20 mole% phosphatidylserine and 80 mole% phosphatidylcholine. The binding parameters obtained were Kd=0.84 microM and n=0.021 micromoles prothrombin bound per micromole phospholipid which is in agreement with literature. Due to the nature of the measurement the method is especially suitable to quantitate binding of prothrombin at concentrations as low as 5 nM prothrombin.
多鳞蝰蛇(中亚沙蝰)毒液中的凝血酶原激活剂——多鳞酶激活凝血酶原的过程,会受到含有带负电荷阴离子磷脂的膜的抑制。这种抑制作用似乎是由于毒液激活剂无法激活膜结合的凝血酶原。在磷脂存在的情况下,多鳞酶激活凝血酶原的初始稳态速率似乎仅取决于未结合的凝血酶原部分,这一现象被用于定量凝血酶原与不同磷脂组成的膜的结合。在该方法中,在不存在促凝表面(总凝血酶原)和存在促凝表面(速率仅取决于游离凝血酶原)的情况下测量多鳞酶激活凝血酶原的初始速率,并根据激活速率的差异计算膜结合凝血酶原的量。通过测定凝血酶原与由20摩尔%磷脂酰丝氨酸和80摩尔%磷脂酰胆碱组成的100微摩尔磷脂囊泡的结合参数,确定了该方法的有效性。获得的结合参数为Kd = 0.84微摩尔,n = 每微摩尔磷脂结合0.021微摩尔凝血酶原,这与文献一致。由于测量的性质,该方法特别适合于定量低至5纳摩尔凝血酶原浓度下的凝血酶原结合。